Correlation Between Monopar Therapeutics and 88579YBG5

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and 88579YBG5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and 88579YBG5 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and 3M MTN, you can compare the effects of market volatilities on Monopar Therapeutics and 88579YBG5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of 88579YBG5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and 88579YBG5.

Diversification Opportunities for Monopar Therapeutics and 88579YBG5

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Monopar and 88579YBG5 is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and 3M MTN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 88579YBG5 and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with 88579YBG5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 88579YBG5 has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and 88579YBG5 go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and 88579YBG5

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 58.18 times more return on investment than 88579YBG5. However, Monopar Therapeutics is 58.18 times more volatile than 3M MTN. It trades about 0.05 of its potential returns per unit of risk. 3M MTN is currently generating about 0.02 per unit of risk. If you would invest  1,675  in Monopar Therapeutics on November 9, 2024 and sell it today you would earn a total of  3,036  from holding Monopar Therapeutics or generate 181.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy97.77%
ValuesDaily Returns

Monopar Therapeutics  vs.  3M MTN

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
88579YBG5 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in 3M MTN are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 88579YBG5 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Monopar Therapeutics and 88579YBG5 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and 88579YBG5

The main advantage of trading using opposite Monopar Therapeutics and 88579YBG5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, 88579YBG5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 88579YBG5 will offset losses from the drop in 88579YBG5's long position.
The idea behind Monopar Therapeutics and 3M MTN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency